These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 12894990)

  • 21. Treatment of hair loss.
    Price VH
    N Engl J Med; 1999 Sep; 341(13):964-73. PubMed ID: 10498493
    [No Abstract]   [Full Text] [Related]  

  • 22. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
    Kaufman KD; Girman CJ; Round EM; Johnson-Levonas AO; Shah AK; Rotonda J
    Eur J Dermatol; 2008; 18(4):407-11. PubMed ID: 18573713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgens and alopecia.
    Kaufman KD
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):89-95. PubMed ID: 12573818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system.
    Shin JW; Chung EH; Kim MB; Kim TO; Kim WI; Huh CH
    J Dermatol; 2019 Feb; 46(2):139-143. PubMed ID: 30536893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finasteride increases anagen hair in men with androgenetic alopecia.
    Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
    Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men.
    Olsen EA
    Exp Dermatol; 1999 Aug; 8(4):302-3. PubMed ID: 10439233
    [No Abstract]   [Full Text] [Related]  

  • 28. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Male pattern baldness.
    Hogan DJ; Chamberlain M
    South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Finasteride in the treatment of men with frontal male pattern hair loss.
    Leyden J; Dunlap F; Miller B; Winters P; Lebwohl M; Hecker D; Kraus S; Baldwin H; Shalita A; Draelos Z; Markou M; Thiboutot D; Rapaport M; Kang S; Kelly T; Pariser D; Webster G; Hordinsky M; Rietschel R; Katz HI; Terranella L; Best S; Round E; Waldstreicher J
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):930-7. PubMed ID: 10365924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
    D'Amico AV; Roehrborn CG
    Lancet Oncol; 2007 Jan; 8(1):21-5. PubMed ID: 17196507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new look at the 5alpha-reductase inhibitor finasteride.
    Finn DA; Beadles-Bohling AS; Beckley EH; Ford MM; Gililland KR; Gorin-Meyer RE; Wiren KM
    CNS Drug Rev; 2006; 12(1):53-76. PubMed ID: 16834758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Androgenetic alopecia in the man].
    Bader U; Trüeb RM
    Ther Umsch; 2002 May; 59(5):211-6. PubMed ID: 12090116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5alpha-reductase inhibitors/finasteride.
    Stoner E
    Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgenetic alopecia; drug safety and therapeutic strategies.
    Motofei IG; Rowland DL; Baconi DL; Tampa M; Sârbu MI; Păunică S; Constantin VD; Bălălău C; Păunică I; Georgescu SR
    Expert Opin Drug Saf; 2018 Apr; 17(4):407-412. PubMed ID: 29363345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hair loss in women with hyperandrogenism: four cases responding to finasteride.
    Shum KW; Cullen DR; Messenger AG
    J Am Acad Dermatol; 2002 Nov; 47(5):733-9. PubMed ID: 12399766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients.
    Moreno-Arrones OM; Becerra A; Vano-Galvan S
    Clin Exp Dermatol; 2017 Oct; 42(7):743-748. PubMed ID: 28691187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hair regrowth. Therapeutic agents.
    Shapiro J; Price VH
    Dermatol Clin; 1998 Apr; 16(2):341-56. PubMed ID: 9589208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.
    Trüeb RM;
    Dermatology; 2004; 209(3):202-7. PubMed ID: 15459533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.